Shafarman Consulting uses standard information models, such as the HL7 Reference Information Model (RIM) and the associated bindings of standard terminologies to understand and resolve interoperability issues. Encouraging and enabling the adoption of healthcare information standards that will support regional, national and international cross-enterprise sharing of healthcare data without loss of meaning is also a major focus. Principal Mark Shafarman MS BA has been a member of HL7 for over 20 years and was its Chairman 2004-05.
● Consulting and expert advice to the Healthcare industry
Membership in Professional Associations/Societies:
● HL7 Global ● HL7 Australia ● ...
Health Level 7 News
HL7 International Appoints Accenture's Andy Truscott to the Board of Directors
Wednesday, 31st January 2018
Health Level Seven® International (HL7®), the global authority for interoperability in healthcare information technology (IT) with members in 55 countries, today announced the appointment of Andy Truscott, managing director of health technology consulting at Accenture, to the HL7 Board of Directors.
HL7 Announces Winners of FHIR Applications Roundtable of Real-World FHIR Solutions
Wednesday, 17th January 2018
Health Level Seven® International (HL7®), the global authority for interoperability in healthcare information technology and home to the Fast Healthcare Interoperability Resources (FHIR®) standard, today announced the winners of the third FHIR® applications roundtable, an event focused on showcasing FHIR-based solutions in use in today's healthcare industry. The organization also announced that the presentation slides and video recordings are now freely available to view on the HL7 website. The HL7 FHIR® Applications Roundtable was held at the LSU Human Development Center in New Orleans, LA on December 6 and 7, 2017 and highlighted 30 FHIR-based solutions available today.
Health Level Seven and TransCelerate BioPharma Working Together to Facilitate Use of eSource for Clinical Research with HL7® FHIR®
Sunday, 3rd December 2017
Health Level Seven® (HL7®) International, the global authority on interoperability of health information technology with members in 55 countries, and TransCelerate BioPharma Inc., a non-profit organization to improve the health of people around the world by simplifying and accelerating the research and development of innovative new therapies, are working together to advance the use of eSource in clinical trials and facilitate interoperability by enabling the use of electronic health records (EHRs) in clinical research, enabled by the use of the HL7® FHIR® platform standard.
Could not find the News you were looking for? Search here: